Literature DB >> 31858356

Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain.

Arina Riabinska1,2, Marietta Zille3,4, Menderes Yusuf Terzi1,5, Ryan Cordell1, Melina Nieminen-Kelhä1, Jan Klohs3,6,7, Ana Luisa Piña8.   

Abstract

Pigment epithelium-derived factor (PEDF) is a neurotrophic factor with neuroprotective, antiangiogenic, and antipermeability effects. In the brain, blood-brain barrier (BBB) function is essential for homeostasis. Its impairment plays a crucial role in the pathophysiology of many neurological diseases, including ischemic stroke. We investigated (a) whether PEDF counteracted vascular endothelial growth factor (VEGF)-induced BBB disruption in the mouse brain, (b) the time course and route of BBB permeability and the dynamics of PEDF expression after cerebral ischemia, and (c) whether intraventricular infusion of PEDF ameliorated brain ischemia by reducing BBB impairment. C57Bl6/N mice received intraparenchymal injections of CSF, VEGF, or a combination of VEGF and PEDF. PEDF increased paracellular but not transcellular BBB integrity as indicated by an increase in the tight junction protein claudin-5. In another group of mice undergoing 60-min middle cerebral artery occlusion (MCAO), transcellular BBB permeability (fibrinogen staining in the absence of a loss of claudin-5) increased as early as 6 h after reperfusion. PEDF immunofluorescence increased at 24 h, which paralleled with a decreased paracellular BBB permeability (claudin-5). PEDF after MCAO originated from the blood stream and endogenous pericytes. In the third experiment, the intraventricular infusion of PEDF decreased edema and cell death after MCAO, potentially mediated by the improvement of the paracellular route of BBB permeability (claudin-5) in the absence of an amelioration of Evans Blue extravasation. Together, our data suggest that PEDF improves BBB function after cerebral ischemia by affecting the paracellular but not the transcellular route. However, further quantitative data of the different routes of BBB permeability will be required to validate our findings.

Entities:  

Keywords:  Blood–brain barrier; Cerebral ischemia; Claudin-5; Fibrinogen; MCAO; Pigment epithelium-derived factor

Mesh:

Substances:

Year:  2019        PMID: 31858356     DOI: 10.1007/s10571-019-00770-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  57 in total

Review 1.  Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches.

Authors:  Filipa Lourenço Cardoso; Dora Brites; Maria Alexandra Brito
Journal:  Brain Res Rev       Date:  2010-05-26

Review 2.  Physiology and pharmacological role of the blood-brain barrier.

Authors:  Jacek Bernacki; Aleksandra Dobrowolska; Katarzyna Nierwińska; Andrzej Małecki
Journal:  Pharmacol Rep       Date:  2008 Sep-Oct       Impact factor: 3.024

Review 3.  Structure and function of the blood-brain barrier.

Authors:  N Joan Abbott; Adjanie A K Patabendige; Diana E M Dolman; Siti R Yusof; David J Begley
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

4.  Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1.

Authors:  Jun Cai; Wen G Jiang; Maria B Grant; Mike Boulton
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

5.  Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome.

Authors:  Raf Brouns; Annick Wauters; Didier De Surgeloose; Peter Mariën; Peter P De Deyn
Journal:  Eur Neurol       Date:  2010-12-07       Impact factor: 1.710

6.  Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats.

Authors:  L Belayev; R Busto; W Zhao; M D Ginsberg
Journal:  Brain Res       Date:  1996-11-11       Impact factor: 3.252

7.  VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown.

Authors:  Azeb Tadesse Argaw; Blake T Gurfein; Yueting Zhang; Andleeb Zameer; Gareth R John
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

Review 8.  Oxidative stress and its role in the pathogenesis of ischaemic stroke.

Authors:  C L Allen; U Bayraktutan
Journal:  Int J Stroke       Date:  2009-12       Impact factor: 5.266

9.  Maintaining blood-brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation.

Authors:  A Al Ahmad; M Gassmann; O O Ogunshola
Journal:  J Cell Physiol       Date:  2009-03       Impact factor: 6.384

10.  PEDF regulates vascular permeability by a γ-secretase-mediated pathway.

Authors:  Jun Cai; Lin Wu; Xiaoping Qi; Sergio Li Calzi; Sergio Caballero; Lynn Shaw; Qing Ruan; Maria B Grant; Michael E Boulton
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

View more
  5 in total

1.  Curcumin ameliorates ischemic stroke injury in rats by protecting the integrity of the blood-brain barrier.

Authors:  Shuguang Wu; Ting Guo; Wenxuan Qi; Yuyu Li; Jie Gu; Cui Liu; Yuehong Sha; Baocheng Yang; Shuqun Hu; Xuemei Zong
Journal:  Exp Ther Med       Date:  2021-05-19       Impact factor: 2.447

2.  Protein Nanoparticle-Related Osmotic Pressure Modifies Nonselective Permeability of the Blood-Brain Barrier by Increasing Membrane Fluidity.

Authors:  Chen Li; LinLin Chen; YuanYuan Wang; TingTing Wang; Dong Di; Hao Zhang; HuanHuan Zhao; Xu Shen; Jun Guo
Journal:  Int J Nanomedicine       Date:  2021-03-01

3.  OM-MSCs Alleviate the Golgi Apparatus Stress Response following Cerebral Ischemia/Reperfusion Injury via the PEDF-PI3K/Akt/mTOR Signaling Pathway.

Authors:  Jialin He; Jianyang Liu; Yan Huang; Xiangqi Tang; Han Xiao; Zuo Liu; Zheng Jiang; Liuwang Zeng; Zhiping Hu; Ming Lu
Journal:  Oxid Med Cell Longev       Date:  2021-11-13       Impact factor: 6.543

Review 4.  Nanocarriers Call the Last Shot in the Treatment of Brain Cancers.

Authors:  Amin Mehrabian; Mohammad Mashreghi; Saba Dadpour; Ali Badiee; Leila Arabi; Seyedeh Hoda Alavizadeh; Seyedeh Alia Moosavian; Mahmoud Reza Jaafari
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

5.  Epigallocatechin-3-Gallate and PEDF 335 Peptide, 67LR Activators, Attenuate Vasogenic Edema, and Astroglial Degeneration Following Status Epilepticus.

Authors:  Ji-Eun Kim; Hana Park; Min-Jeong Jeong; Tae-Cheon Kang
Journal:  Antioxidants (Basel)       Date:  2020-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.